Real-world opportunity of empagliflozin to improve blood pressure control in African American patients with type 2 diabetes: A National Cardiovascular Data Registry “research-to-practice” project from the diabetes collaborative registry

The 1245.29 trial recently showed that empaglifozin improved both blood pressure and glucose control in African American (AA) patients with type 2 diabetes (T2D) and hypertension. Using the Diabetes Collaborative Registry (DCR), a large-scale US registry of outpatients with diabetes recruited from p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Obes Metab
Hlavní autoři: Arnold, Suzanne V., Seman, Leo, Tang, Fengming, Peri-okonny, Poghni A., Ferdinand, Keith C., Mehta, Sanjeev N., Goyal, Abhinav, Sperling, Laurence S., Kosiborod, Mikhail
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7032959/
https://ncbi.nlm.nih.gov/pubmed/30136353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13510
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky